Presentations

 

Symptom Management of Hormonal Syndromes in NEC
Daria Arbogast, CNP, MSN, AOCN, APRN-BC
The Ohio State University Comprehensive Cancer Center -James Cancer Hospital and Solove Research Institute

Surgical Management of Liver Metastasis in NEC: Primary GI Carcinoids and Pancreatic NET
Mark Bloomston, MD
Associate Professor of Surgery
Division of Surgical Oncology
The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute

Clinical Trials in NEC: How to Find and When to Refer?
Minden Collamore
Clinical Research Coordinator
Clinical Trials Office
The Ohio State University Comprehensive Cancer Center James Cancer Hospital and Solove Research Institute

Peri-procedure Care of TACE Patients
Gail Davidson, RN, BSN, OCN
Regional Liver Therapy Disease Management Coordinator
Division of Surgical Oncology
The Ohio State University Comprehensive Cancer Center -James Cancer Hospital and Solove Research Institute

Pathology of Neuroendocrine Cancers: Well-to Poorly-differentiated Neuroendocrine Carcinomas
Wendy L. Frankel, MD
Professor, Department of Pathology
Vice Chair and Director, Anatomic Pathology
Director, GI and Liver Pathology
The Ohio State University Comprehensive Cancer Center James Cancer Hospital and Solove Research Institute

Transarterial Chemo Embolization of Liver Metastases in NEC
Hooman Khabiri, MD
Assistant Professor
Department of Radiology
The Ohio State University Medical Center

VEGF Targeted Therapies in NEC: Why and How to Give?
Diane Reidy-Lagunes, MD
Assistant Attending Physician
Department of Medicine
Gastrointestinal Oncology Service
Memorial Sloan Kettering Cancer Center

Overview of Carcinoid Tumors: Clinical Presentation, Diagnosis and Staging of NEC
Thomas O'Dorisio, MD
Professor, Department of Internal Medicine
Division of Endocrine-Metabolism
University of Iowa 

Genetics of NEC: Who Should be Referred and and in whom to do Genetic Testing?
Rebecca Nagy, CGC
Department of Human Genetics
The Ohio State University Comprehensive Cancer Center James Cancer Hospital and Solove Research Institute

Surgical Management of Primary Tumor in NEC: Primary GI Carcinoids and Pancreatic NETC
Carl R. Schmidt, MD
Assistant Professor of Surgery
Division of Surgical Oncology
The Ohio State University Comprehensive Cancer Center James Cancer Hospital and Solove Research Institute 

Cytotoxic Chemotherapy, Octreotide analogs and PRRT in NEC: Why and How to Give?
Manisha H. Shah, MD
Associate Professor of Internal Medicine
Director, Neuroendocrine Tumor Program
Division of Medical Oncology
The Ohio State University Comprehensive Cancer Center -James Cancer Hospital

mTOR Inhibitors in NEC: Why, When, and How to Give?
James C. Yao, MD
Associate Professor of Internal Medicine
Department of Gastrointestinal Medical Oncology
Division of Cancer Medicine
University of Texas
MD Anderson Cancer Center

 

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) 300 W. 10th Ave. Columbus, OH 43210 Phone: 1-800-293-5066 | Email: jamesline@osumc.edu